Berberine and weight loss: real effects, limitations and precautions

Presented on social media as a "natural Ozempic", berberine has become in a few months among the most searched active ingredients in the world of slimming dietary supplements. This yellow alkaloid is extracted from plants such as barberry, Canadian yellow dot, or coptis. It has long been used in Asian pharmacopoeias, and its interest for research is real: it acts on several mechanisms involved in the management of energy and blood sugar.

Between a measured effect in the laboratory and a visible result on the scale, the gap is nevertheless considerable. The subject berberine and weight loss therefore deserves a rigorous reading. It is necessary to look at what clinical trials really show, how the molecule works and what distinguishes it from GLP-1 analogues. It is also necessary to understand why health authorities are calling for caution today.

The answer is one sentence: the effect of berberine on weight loss exists, but it is weak, inconsistent and observed mainly in specific profiles.

Several meta-analyses of randomized controlled trials have evaluated the link between berberine and weight loss. Their method is comparable: group trials conducted over a few weeks to a few months, in adults who most often receive between 500 and 1,500 mg of berberine per day.

The results converge towards a modest order of magnitude: an average drop of about 1 to 2 kg compared to placebo. Some syntheses, built on a different set of trials, do not even find a significant effect on total weight.

This heterogeneity is explained in three ways. First, the participants differ greatly from one study to another, and a large part of the trials concern people who already have a metabolic imbalance. In addition, the doses and follow-up durations vary. Finally, many studies are small and conducted in a single country, which limits their scope. In other words, weight loss with berberine is neither significant nor guaranteed.

The figure displayed by the scale adds body fat, muscle mass and water. A variation of one or two kilos can therefore reflect very different realities, including a simple water fluctuation.

This is why researchers also follow the waist circumference, a better reflection of abdominal fat. On this criterion, several trials report a decrease of about 1 to 3 cm depending on the protocols. The effect is more regular than on total weight, but remains limited in absolute value.

The fat loss itself, measured by impedancemetry or absorptiometry, is still rarely evaluated. The available data remain inconclusive. The question arises for all the active ingredients presented as fat burners, whose real effectiveness of fat burners is analyzed in a dedicated article. In view of these results, presenting berberine as a slimming product would be misleading. No health claim is authorized for berberine in the European Union either.

If its effect on the scale remains modest, it is on metabolism that berberine has been most studied. Understanding these mechanisms allows to better situate what it can, or not, bring in a weight loss approach.

AMPK (AMP-activated protein kinase) works as an energy sensor of the cell. It activates naturally when energy reserves decrease, for example during physical effort or a period of fasting. Once activated, it directs metabolism towards the use of glucose and fatty acids, and slows down storage pathways.

Work on cells and animal models, published as early as 2006 in the journal Diabetes, showed that berberine activates this enzyme. This is the mechanism most often advanced to explain its metabolic effects.

A nuance is however necessary. The oral bioavailability of berberine is very low, estimated at less than 1%. A part of its action could therefore pass through the intestine and the microbiota, rather than through a direct effect on tissues. A mechanism demonstrated in vitro does not guarantee a visible effect in humans.

Blood sugar is the most documented parameter. Several clinical trials, including a study published in 2008 in the journal Metabolism, measured an improvement in glycemic markers in adults presenting an established metabolic imbalance. These same works report effects on insulin sensitivity, that is, the ability of cells to respond to this hormone.

In a person whose metabolism works normally, these effects are clearly less marked, or even absent. The results obtained in a context of insulin resistance cannot therefore be transposed to someone who simply wants to lose a few kilos.

Above all, a better balanced metabolism is not enough to make you lose weight. Fat loss depends above all on the balance between energy consumed and energy spent, which berberine only changes marginally.

The expression rests on two ideas: berberine would cut hunger, and it would act like GLP-1 analogues. Neither of the two withstands the examination of the data.

No solid clinical trial has demonstrated in humans a direct effect of berberine on appetite or satiety. The hypotheses advanced rest essentially on animal models.

An indirect link remains plausible. A more stable blood sugar after meals can limit certain cravings linked to sudden variations in blood sugar, especially after a meal with a high glycemic index. It is however a consequence of better glucose management, and not an appetite suppressant action. Its magnitude varies strongly from one person to another.

GLP-1 is a hormone produced by the intestine after meals. It stimulates insulin secretion, slows gastric emptying and acts on the brain to decrease hunger. Its natural lifespan does not exceed a few minutes.

Semaglutide (Ozempic, Wegovy) is a synthetic analogue of this hormone, designed to remain active for several days at concentrations much higher than those of natural GLP-1. In the STEP 1 trial, published in 2021 in the New England Journal of Medicine, it led to a loss of about 15% of body weight in 68 weeks.

Berberine, on the other hand, could slightly favor the natural secretion of GLP-1, according to work conducted on cells and in animals. But a modest and transitory stimulation of a natural hormone is nothing comparable with a long-acting analogue. On weight loss, the difference in magnitude is of the order of ten times. The nickname "natural Ozempic" therefore rests on no scientific basis. The functioning of this hormone and the molecules that imitate it is detailed in the article dedicated to GLP-1 and weight loss.

The data on berberine and weight loss call for an even greater caution as the safety of this substance is today the subject of a European evaluation.

In clinical trials, the most frequent dosage is between 900 and 1,500 mg per day, divided into two or three doses of 500 mg at mealtime. The durations range from a few weeks to a few months.

These quantities correspond to research protocols, not usage recommendations. To date, there is no validated berberine protocol for weight loss.

Two other factors suggest that doses should not be increased. On the one hand, data do not show a simple relationship between a higher dose and greater weight loss, partly due to low absorption. On the other hand, digestive side effects increase with the dose. ANSES also considers that from 400 mg per day, berberine exerts pharmacological effects.

The most frequent side effects are digestive: bloating, abdominal discomfort, and changes in bowel movements. They are generally mild and disappear when intake is stopped.

Available data do not show a simple relationship between a higher dose and a greater effect on weight. Berberine is also poorly absorbed by the body, which limits its actual availability in the blood. Increasing the amount taken therefore does not necessarily improve results, while increasing the risk of digestive issues.

ANSES recommends that several groups avoid any dietary supplement containing berberine:

• children and adolescents;
• pregnant or breastfeeding women;
• people whose blood sugar is medically monitored;
• people with a history of liver or heart problems;
• people currently taking a prescription.

In the event of pregnancy or breastfeeding, it is important to seek advice from a healthcare professional before taking any supplements.

For all other groups, the advice of a doctor or pharmacist remains essential before considering berberine for weight loss. Only they can assess possible interactions and the appropriateness of this approach for each individual's situation. ANSES also advises against combining berberine with other dietary supplements containing numerous ingredients.

This is a constant of evidence-based nutrition, and the principle that guides Biocyte, the leading French nutricosmetics laboratory: no isolated active ingredient can replace the lifestyle changes whose effectiveness is proven.

The first factor is the plate. Proteins, fiber, and minimally processed foods naturally promote satiety. When the diet provides little of it, a dietary supplement rich in fiber can help supplement intake. Some fibers, such as glucomannan, even benefit from an authorized health claim as part of a low-calorie diet: this is the principle of fiber-based appetite suppressants.

To better manage blood sugar, it is not necessary to cut out carbohydrates. It is enough to favor whole grains and legumes, and to start the meal with vegetables and proteins before starches. A few minutes walk after the meal also helps limit the blood sugar spike.

Regular physical activity, which combines endurance and muscle work, preserves lean mass during weight loss. Sleep is just as important: sleep deprivation alters the hunger hormones, ghrelin and leptin, and drives toward more caloric food choices. Good sleep hygiene, possibly accompanied by supplements dedicated to sleep and stress management, is an integral part of a sustainable approach.

In this comprehensive approach, dietary supplements find their place in support of a balanced diet and physical activity, never as a substitute, as detailed in the guide how to lose weight thanks to dietary supplements. Finally, when weight represents a health issue, or when the efforts made are not enough, support from a doctor or dietitian allows to build a strategy adapted and monitored over time.

• ANSES (2019). Opinion on the risks associated with the use of plants containing berberine in the composition of dietary supplements. Referral No. 2018-SA-0095.

• EFSA, NDA panel (2026). Draft Scientific Opinion on the safety of plant preparations containing berberine, approved on January 29, 2026 and submitted for public consultation. The status of the final opinion is to be verified.

• Asbaghi O. et al. (2020). Effects of berberine supplementation on anthropometric parameters: meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN.

• Ilyas Z. et al. (2020). The effect of berberine on weight loss: a systematic review. Biomedicine & Pharmacotherapy.

• Lee Y.S. et al. (2006). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects. Diabetes, 55(8).

• Yin J., Xing H., Ye J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5).

• Yu Y. et al. (2010). Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochemical Pharmacology, 79(7).

• Wilding J.P.H. et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 384.